• Licencing agreement adds to growing use of CRISPR technology
    Carlo Toniatti
  • John E. Milad

Company News

Licencing agreement adds to growing use of CRISPR technology

Jun 11 2024

Drug discovery company IRBM (Rome) has signed a non-exclusive agreement granting access to ERS Genomics’ CRISPR/Cas9 patent portfolio. The Italian CRO offers expertise ranging from target validation and hit finding to preclinical candidate nomination across various therapeutic areas, including oncology, infectious diseases and neuroscience. The company has contributed to the discovery and development of four marketed therapeutics for HIV, HCV, ovarian cancer and cutaneous T-cell lymphoma.

Carlo Toniatti, MD, PhD, CSO, IRBM, said: “We are committed to delivering high quality drugs by leveraging our broad range of expertise and capabilities across the entire preclinical drug discovery continuum. With the integration of CRISPR/Cas9 gene editing technology we are increasing our capability to identify and validate potential drug targets, to generate more predictive pre-clinical models and to elucidate the mechanisms of action of novel therapeutics.”

John E Milad, CEO, of Dublin-based ERS Genomics, commented: “We are committed to supporting cutting-edge research and expanding the horizons of medical innovation by providing companies such as IRBM with the ability to take advantage of CRISPR/Cas9 technology. We look forward to seeing the innovative ways in which our gene editing technology will be utilised in various stages of drug discovery, providing candidates for a wide range of therapeutic areas.”

ERS Genomics provides licensing to CRISPR/Cas9 technology for all cells, including eukaryotic and prokaryotic cells such as mammalian cells, bacteria, archaea, yeasts, algae, and insects, through its direct licence from Emmanuelle Charpentier and now has nearly 150 licenses in place worldwide.

More information online

Digital Edition

Lab Asia 31.3 June 2024

June 2024

Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - UV-Vis and fluorescence spectroscopy illumina...

View all digital editions



Jun 26 2024 Tokyo, Japan

Asia Labex

Jul 03 2024 Gandhinagar, India

EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

View all events